Dyne Therapeutics, Inc.

United States of America


 
Total IP 210
Total IP Rank # 6,125
IP Activity Score 3.2/5.0    280
IP Activity Rank # 2,537
Stock Symbol DYN (nasdaq)
ISIN US26818M1080
Market Cap. 2,900M  (USD)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

74 23
39 4
55 13
2
 
Last Patent 2025 - Muscle targeting complexes for t...
First Patent 2019 - Muscle targeting complexes and u...
Last Trademark 2024 - DYLAMPIK
First Trademark 2018 - DYNE THERAPEUTICS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Pharmaceutical preparations for treating muscle diseases or disorders; pharmaceutical preparatio...
G/S Pharmaceutical preparations for treating muscle diseases or disorders; pharmaceutical preparation...
Invention Muscle targeting complexes and uses thereof for treating dystrophinopathies. Aspects of the disc...
Invention Muscle targeting complexes and uses thereof for treating myotonic dystrophy. Aspects of the disc...
Invention Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide. Aspects ...
Invention Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonuc...
G/S Providing medical and scientific research information in the field of pharmaceuticals. Providing ...
G/S Providing medical and scientific research information in the field of pharmaceuticals. Providing...
Invention Muscle targeting complexes and uses thereof for treating myotonic dystrophy. Aspects of the discl...
Invention Muscle targeting complexes and uses thereof for treating dystrophinopathies. Aspects of the discl...
Invention Methods and compositions for inhibiting progression of intramuscular fibrosis. The present applic...
G/S Pharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparatio...
Invention Muscle targeting complexes and formulations for treating myotonic dystrophy. Aspects of the disc...
2023 Invention Muscle targeting complexes and uses thereof for skipping exon 45 of a dmd gene. Aspects of the di...
G/S Providing medical and scientific research information in the field of pharmaceuticals Providing i...
Invention Muscle targeting complexes and formulations for treating dystrophinopathies. Aspects of the discl...
G/S Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac di...
Invention Cns targeting complexes and uses thereof. The present application relates to complexes comprising...
Invention Muscle targeting complexes and formulations for treating myotonic dystrophy. Aspects of the discl...
Invention Dosing of muscle targeting complexes for treating myotonic dystrophy. Aspects of the disclosure r...
Invention Anti-transferrin receptor antibody and uses thereof. Aspects of the disclosure relate to antibodi...
2022 Invention Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy. Aspects of the d...
Invention Dosing of muscle targeting complexes for treating dystrophinopathies. Aspects of the disclosure ...
Invention Muscle targeting complexes and uses thereof for treating myotonic dystrophy. The present applica...
Invention Muscle targeting complexes and uses thereof for modulation of genes associated with muscle health...
Invention Muscle targeting complexes and uses thereof for treating pompe disease. Aspects of the disclosur...
Invention Muscle targeting complexes and uses thereof for treating friedreich's ataxia. The present applic...
2021 Invention Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy. ...
Invention Antibody-oligonucleotide complexes and uses thereof. Provided herein are oligonucleotide-antibod...
Invention Methods of preparing protein-oligonucleotide complexes. Aspects of the disclosure relate to meth...
Invention Muscle-targeting complexes and uses thereof in treating muscle atrophy. Aspects of the disclosur...
Invention Muscle-targeting complexes and uses thereof. Aspects of the disclosure relate to complexes compr...
2018 G/S Pharmaceutical preparations for treating muscle diseases or disorders